T/CACM 1170-2019 Active Group standards

T/CACM 1170-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CACM 1170-2019

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medicine

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2019-01-30

Implement Date: 2020-01-01

Scope

Main technical content: This guideline provides recommendations for the diagnosis, differentiation, treatment, prevention, and care of pulmonary diseases and/or pulmonary arterial hypertension caused by hypoxia, as well as chronic thromboembolic pulmonary arterial hypertension. This guideline is applicable to the diagnosis and prevention of pulmonary diseases and/or pulmonary arterial hypertension caused by hypoxia in people aged 18 and above. It is suitable for use by clinicians in departments such as traditional Chinese medicine, respiratory medicine, cardiology, and ultrasound. This guideline does not cover arterial pulmonary hypertension, pulmonary arterial hypertension caused by left-sided heart diseases, or pulmonary arterial hypertension of unknown or multifactorial origin.